Titre : Ellipticines

Ellipticines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Electronic Data Processing
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Ellipticines : Questions médicales les plus fréquentes", "headline": "Ellipticines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Ellipticines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-02", "dateModified": "2025-03-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Ellipticines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carbazoles", "url": "https://questionsmedicales.fr/mesh/D002227", "about": { "@type": "MedicalCondition", "name": "Carbazoles", "code": { "@type": "MedicalCode", "code": "D002227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.148" } } }, "about": { "@type": "MedicalCondition", "name": "Ellipticines", "alternateName": "Ellipticines", "code": { "@type": "MedicalCode", "code": "D004611", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elaine C O'Sullivan", "url": "https://questionsmedicales.fr/author/Elaine%20C%20O%27Sullivan", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland." } }, { "@type": "Person", "name": "Florence O McCarthy", "url": "https://questionsmedicales.fr/author/Florence%20O%20McCarthy", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland." } }, { "@type": "Person", "name": "Hao Lu", "url": "https://questionsmedicales.fr/author/Hao%20Lu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China." } }, { "@type": "Person", "name": "Manli Liu", "url": "https://questionsmedicales.fr/author/Manli%20Liu", "affiliation": { "@type": "Organization", "name": "Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan, China." } }, { "@type": "Person", "name": "Wenjia Lu", "url": "https://questionsmedicales.fr/author/Wenjia%20Lu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Using Natural Language Processing and Machine Learning to Identify Opioids in Electronic Health Record Data.", "datePublished": "2023-06-20", "url": "https://questionsmedicales.fr/article/37361429", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/JPR.S389160" } }, { "@type": "ScholarlyArticle", "name": "Using natural language processing to identify opioid use disorder in electronic health record data.", "datePublished": "2022-12-10", "url": "https://questionsmedicales.fr/article/36521420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijmedinf.2022.104963" } }, { "@type": "ScholarlyArticle", "name": "Prediction of intra-abdominal injury using natural language processing of electronic medical record data.", "datePublished": "2024-07-06", "url": "https://questionsmedicales.fr/article/38972771", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.surg.2024.05.042" } }, { "@type": "ScholarlyArticle", "name": "Cerebrovascular disease case identification in inpatient electronic medical record data using natural language processing.", "datePublished": "2023-09-02", "url": "https://questionsmedicales.fr/article/37658963", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40708-023-00203-w" } }, { "@type": "ScholarlyArticle", "name": "Advanced processing of differential phase contrast data: Distinction between different causes of electron phase shifts.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37209502", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ultramic.2023.113752" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Carbazoles", "item": "https://questionsmedicales.fr/mesh/D002227" }, { "@type": "ListItem", "position": 6, "name": "Ellipticines", "item": "https://questionsmedicales.fr/mesh/D004611" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Ellipticines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Ellipticines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Ellipticines", "description": "Comment diagnostiquer une tumeur sensible aux ellipticines ?\nQuels tests sont utilisés pour évaluer l'efficacité des ellipticines ?\nLes ellipticines sont-elles utilisées pour tous les types de cancer ?\nQuels signes cliniques indiquent un traitement par ellipticines ?\nComment évaluer les effets secondaires des ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Electronic+Data+Processing&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Ellipticines", "description": "Quels symptômes peuvent indiquer un cancer traité par ellipticines ?\nLes ellipticines provoquent-elles des effets secondaires ?\nComment reconnaître une réaction allergique aux ellipticines ?\nLes ellipticines affectent-elles le système immunitaire ?\nQuels signes indiquent une toxicité des ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Electronic+Data+Processing&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Ellipticines", "description": "Peut-on prévenir les cancers traités par ellipticines ?\nQuels facteurs de risque sont associés aux cancers traités par ellipticines ?\nLes vaccinations peuvent-elles aider à prévenir le cancer ?\nComment un mode de vie sain influence-t-il le risque de cancer ?\nLes examens de santé réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Electronic+Data+Processing&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Ellipticines", "description": "Comment les ellipticines sont-elles administrées ?\nLes ellipticines sont-elles utilisées en monothérapie ?\nQuel est le mécanisme d'action des ellipticines ?\nQuelles sont les alternatives aux ellipticines ?\nComment surveiller l'efficacité du traitement par ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Electronic+Data+Processing&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Ellipticines", "description": "Quelles complications peuvent survenir avec les ellipticines ?\nLes ellipticines peuvent-elles causer des dommages aux organes ?\nComment gérer les effets secondaires graves des ellipticines ?\nLes ellipticines augmentent-elles le risque de récidive du cancer ?\nQuels sont les risques de surdosage d'ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Electronic+Data+Processing&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Ellipticines", "description": "Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?\nL'hérédité joue-t-elle un rôle dans le risque de cancer ?\nL'alimentation influence-t-elle le risque de cancer ?\nLe stress est-il un facteur de risque pour le cancer ?\nLes infections virales augmentent-elles le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Electronic+Data+Processing&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur sensible aux ellipticines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par biopsie et analyses histopathologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des ellipticines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie comme l'IRM et des marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Les ellipticines sont-elles utilisées pour tous les types de cancer ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement efficaces contre certains cancers comme le cancer du poumon." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un traitement par ellipticines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de progression tumorale ou de résistance aux autres traitements peuvent indiquer leur utilisation." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des ellipticines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont évalués par des examens cliniques et des questionnaires de qualité de vie." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un cancer traité par ellipticines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fatigue, perte de poids et changements d'appétit." } }, { "@type": "Question", "name": "Les ellipticines provoquent-elles des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent causer nausées, vomissements, et troubles hématologiques." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux ellipticines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons ou gonflements peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Les ellipticines affectent-elles le système immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner une immunosuppression, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quels signes indiquent une toxicité des ellipticines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité incluent fatigue extrême, saignements inhabituels et jaunisse." } }, { "@type": "Question", "name": "Peut-on prévenir les cancers traités par ellipticines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures préventives incluent un mode de vie sain et des dépistages réguliers." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux cancers traités par ellipticines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des agents carcinogènes et des antécédents familiaux." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir le cancer ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer." } }, { "@type": "Question", "name": "Comment un mode de vie sain influence-t-il le risque de cancer ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant alimentation équilibrée et exercice, peut réduire le risque." } }, { "@type": "Question", "name": "Les examens de santé réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement des anomalies et d'initier un traitement rapide." } }, { "@type": "Question", "name": "Comment les ellipticines sont-elles administrées ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement administrées par voie intraveineuse ou orale." } }, { "@type": "Question", "name": "Les ellipticines sont-elles utilisées en monothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être utilisées seules ou en association avec d'autres traitements anticancéreux." } }, { "@type": "Question", "name": "Quel est le mécanisme d'action des ellipticines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles agissent en interférant avec l'ADN des cellules cancéreuses, inhibant leur prolifération." } }, { "@type": "Question", "name": "Quelles sont les alternatives aux ellipticines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les alternatives incluent d'autres chimiothérapies, thérapies ciblées et immunothérapies." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement par ellipticines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est surveillée par des examens d'imagerie et des bilans sanguins réguliers." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les ellipticines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des saignements et des réactions allergiques." } }, { "@type": "Question", "name": "Les ellipticines peuvent-elles causer des dommages aux organes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des toxicités hépatiques et rénales, nécessitant une surveillance." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires graves des ellipticines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut l'ajustement de la dose, l'utilisation de médicaments symptomatiques et le suivi." } }, { "@type": "Question", "name": "Les ellipticines augmentent-elles le risque de récidive du cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire le risque de récidive, mais un suivi régulier est essentiel." } }, { "@type": "Question", "name": "Quels sont les risques de surdosage d'ellipticines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le surdosage peut entraîner des effets toxiques graves, nécessitant une intervention médicale immédiate." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'âge." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans le risque de cancer ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer certaines tumeurs." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de cancer ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque pour le cancer ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Bien que le stress ne soit pas un facteur direct, il peut affecter le système immunitaire." } }, { "@type": "Question", "name": "Les infections virales augmentent-elles le risque de cancer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales, comme le HPV, sont liées à un risque accru de cancer." } } ] } ] }

Sources (10000 au total)

Using Natural Language Processing and Machine Learning to Identify Opioids in Electronic Health Record Data.

This study evaluates the utility of machine learning (ML) and natural language processing (NLP) in the processing and initial analysis of data within the electronic health record (EHR). We present and... A total of 4216 distinct medication entries were obtained from the EHR and were initially labeled by human reviewers as opioid or non-opioid medications. An approach incorporating bag-of-words NLP and... A total of 3991 medication strings were classified as non-opioid medications (94.7%), and 225 were classified as opioid medications by the human reviewers (5.3%). The algorithm achieved a 99.6% accura... The automated approach achieved excellent performance in classifying opioids or non-opioids, even with a practical number of human reviewed training examples. This will allow a significant reduction i...

Using natural language processing to identify opioid use disorder in electronic health record data.

As opioid prescriptions have risen, there has also been an increase in opioid use disorder (OUD) and its adverse outcomes. Accurate and complete epidemiologic surveillance of OUD, to inform prevention... Data were drawn from EHR records for hospital and emergency department patient visits to a large regional academic medical center from 2017 to 2019. International Classification of Disease, 10th Editi... While there was substantial overlap in the identified records (n = 1,381 [59.2 %]), overall n = 2,332 unique visits were identified. Of the total unique visits, 430 (18.4 %) were identified only by IC... NLP-based algorithms can automate data extraction and identify evidence of opioid use disorder from unstructured electronic healthcare records. The most complete ascertainment of OUD in EHR was combin...

Prediction of intra-abdominal injury using natural language processing of electronic medical record data.

This study aimed to use natural language processing to predict the presence of intra-abdominal injury using unstructured data from electronic medical records.... This was a random-sample retrospective observational cohort study leveraging unstructured data from injured patients taken to one of 9 acute care hospitals in an integrated health system between 2015 ... A random sample of 7,000 patient encounters of 177,127 was annotated. Only 2,951 had sufficient information to determine whether an intra-abdominal injury was present. Among those, 84 (2.9%) had an in... Natural language processing could be a screening decision support tool, which, if paired with human clinical assessment, can maximize precision of intra-abdominal injury identification....

Cerebrovascular disease case identification in inpatient electronic medical record data using natural language processing.

Abstracting cerebrovascular disease (CeVD) from inpatient electronic medical records (EMRs) through natural language processing (NLP) is pivotal for automated disease surveillance and improving patien... CeVD status was confirmed through a chart review on randomly selected hospitalized patients who were 18 years or older and discharged from 3 hospitals in Calgary, Alberta, Canada, between January 1 an... Of the study sample (n = 3036), the prevalence of CeVD was 11.8% (n = 360); the median patient age was 63; and females accounted for 50.3% (n = 1528) based on chart data. Among 49 extracted clinical d... The NLP algorithm developed in this study performed better than the ICD code algorithm in detecting CeVD. The NLP models could result in an automated EMR tool for identifying CeVD cases and be applied...

Assessing longitudinal housing status using Electronic Health Record data: a comparison of natural language processing, structured data, and patient-reported history.

Measuring long-term housing outcomes is important for evaluating the impacts of services for individuals with homeless experience. However, assessing long-term housing status using traditional methods... We compared VA EHR indicators of housing instability, including information extracted from clinical notes using natural language processing (NLP), with patient-reported housing outcomes in a cohort of... NLP achieved higher sensitivity and specificity than standard diagnosis codes for detecting episodes of unstable housing. Other structured data elements in the VA EHR showed promising performance, par... Evaluation efforts and research studies assessing longitudinal housing outcomes should incorporate multiple data sources of documentation to achieve optimal performance....

Retrospective study of propionic acidemia using natural language processing in Mayo Clinic electronic health record data.

Propionic acidemia (PA) is a rare autosomal recessive organic acidemia that classically presents within the first days of life with a metabolic crisis or via newborn screening and is confirmed with la... To retrospectively describe the natural history of patients with PA in a clinical setting from a real-world database using both structured and unstructured electronic health record (EHR) data using no... This retrospective study used EHR data to identify patients with PA seen at the Mayo Clinic. Unstructured clinical text (medical notes, pathology reports) were analyzed using augmented curation natura... In total, 13 patients with PA were identified, with visits occurring from 1998 to 2022. Age at diagnosis ranged from birth to 3 years; age at initial evaluation at the Mayo Clinic ranged from 3 days t... This study highlights the range and frequency of clinical outcomes experienced by patients with PA and demonstrates the clinical burden of MDEs....

Evaluation of electronic screening in the preoperative process.

Rising patient numbers, with increasing complexity, challenge the sustainability of the current preoperative process. We evaluated whether an electronic screening application can distinguish patients ... Prospective cohort study.... Preoperative clinic of a tertiary academic hospital.... 1395 adult patients scheduled for surgery or procedural sedation.... We assessed a novel electronic preoperative screening application which consists of a questionnaire with a maximum of 185 questions regarding the patient's medical history and current state of health.... The recommendation of the electronic screening system was compared with the regular preoperative assessment using measures of diagnostic accuracy and agreement. Secondary outcomes included ASA-PS clas... Sensitivity to detect patients who needed additional consultation was 97.5% (95%CI 91.2-99.7) and the negative likelihood ratio was 0.08 (95%CI 0.02-0.32). 407 (29.2%) patients were approved for surge... Electronic screening can reliably identify patients who can have their first contact with an anesthesiologist on the day of surgery, potentially allowing a major proportion of patients to safely bypas...